Lundbeck
HLUN-B.CO
#2584
Rank
S$7.40 B
Marketcap
$7.77
Share price
0.10%
Change (1 day)
23.68%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$3.16 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are S$3.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$3.00 B-6.65%
2022-12-31S$3.21 B-4.49%
2021-12-31S$3.37 B-19.13%
2020-12-31S$4.16 B-3.44%
2019-12-31S$4.31 B135.38%
2018-12-31S$1.83 B12.26%
2017-12-31S$1.63 B-24.21%
2016-12-31S$2.15 B-17.1%
2015-12-31S$2.59 B-0.54%
2014-12-31S$2.61 B9.58%
2013-12-31S$2.38 B31.49%
2012-12-31S$1.81 B3.63%
2011-12-31S$1.75 B10.62%
2010-12-31S$1.58 B-29.71%
2009-12-31S$2.25 B67.15%
2008-12-31S$1.34 B-6.98%
2007-12-31S$1.44 B9.43%
2006-12-31S$1.32 B21.33%
2005-12-31S$1.09 B0.05%
2004-12-31S$1.08 B